National Research (NRC) Expected to Announce Earnings on Tuesday

National Research (NASDAQ:NRC) is expected to be announcing its Q2 2026 results before the market opens on Tuesday, July 28th. Analysts expect National Research to post earnings of ($0.15) per share and revenue of $34.90 million for the quarter. Interested persons can check the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Tuesday, July 28, 2026 at 10:00 AM ET.

National Research (NASDAQ:NRC) last issued its earnings results on Tuesday, April 28th. The company reported $0.21 earnings per share (EPS) for the quarter. The business had revenue of $34.80 million during the quarter. National Research had a return on equity of 122.73% and a net margin of 6.52%.

National Research Price Performance

National Research stock opened at $21.04 on Friday. The business has a 50 day simple moving average of $20.33 and a 200 day simple moving average of $18.30. The company has a debt-to-equity ratio of 5.48, a current ratio of 0.52 and a quick ratio of 0.52. The company has a market capitalization of $478.66 million, a PE ratio of 53.95 and a beta of 0.35. National Research has a one year low of $11.01 and a one year high of $23.00.

Wall Street Analyst Weigh In

NRC has been the subject of several recent analyst reports. Weiss Ratings upgraded National Research from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 29th. Citizens Jmp assumed coverage on shares of National Research in a research note on Monday, June 22nd. They issued a “market outperform” rating and a $23.00 target price on the stock. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $23.00.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. AQR Capital Management LLC boosted its holdings in shares of National Research by 86.2% in the 2nd quarter. AQR Capital Management LLC now owns 201,396 shares of the company’s stock worth $3,383,000 after acquiring an additional 93,262 shares in the last quarter. Heartland Advisors Inc. acquired a new stake in National Research during the 4th quarter valued at $938,000. Jane Street Group LLC increased its holdings in National Research by 394.2% during the 1st quarter. Jane Street Group LLC now owns 52,411 shares of the company’s stock valued at $671,000 after purchasing an additional 41,806 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its position in National Research by 180.8% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 49,076 shares of the company’s stock valued at $627,000 after purchasing an additional 31,599 shares during the last quarter. Finally, Two Sigma Investments LP raised its position in National Research by 99.0% in the 3rd quarter. Two Sigma Investments LP now owns 60,912 shares of the company’s stock valued at $778,000 after purchasing an additional 30,296 shares during the last quarter. Institutional investors own 47.26% of the company’s stock.

National Research Company Profile

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.